跳至主要内容
临床试验/CTRI/2023/08/057144
CTRI/2023/08/057144招募中2 期

A pilot randomized controlled clinical trial to evaluate thehepatoprotective effect of Liv-Ever (Punarnava – Boerhaviadiffusa -tablet) in patients with elevated liver enzyme panel - nil

niversity of Kerala0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects of either gender with an age group between 18 - 70 years
  • Subjects having elevated liver enzymes panel due to multiple causes like obesity, hyper
  • triglyceridemia, drug induced liver disease etc.
  • Subjects with fluctuating liver enzyme panel due to unknown reasons.
  • Subjects who are willing to sign the informed consent form

排除标准

  • Patients with chronic liver diseases
  • Pregnant and lactating women
  • Suspected malignant conditions.

研究者

发起方
niversity of Kerala

相似试验